176 related articles for article (PubMed ID: 11770793)
1. The treatment of anemia in peritoneal dialysis patients.
Lacson E; Diaz-Buxo JA
Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients.
Auerbach M; Winchester J; Wahab A; Richards K; McGinley M; Hall F; Anderson J; Briefel G
Am J Kidney Dis; 1998 Jan; 31(1):81-6. PubMed ID: 9428456
[TBL] [Abstract][Full Text] [Related]
4. [Anemia syndrome in patients with chronic renal insufficiency on peritoneal dialysis treated with recombinant erythropoietin].
Romanova LA; Lugovskaia SA; Khareb F; Shumov EV; Shmarov DA
Urologiia; 2002; (5):26-30. PubMed ID: 12402772
[TBL] [Abstract][Full Text] [Related]
5. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
Daschner M; Mehls O; Schaefer F
Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
[TBL] [Abstract][Full Text] [Related]
6. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of bolus intravenous iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin.
Ahsan N; Groff JA; Waybill MA
Adv Perit Dial; 1996; 12():161-6. PubMed ID: 8865893
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and iron use in peritoneal dialysis patients. Report from the 1997 HCFA end-stage renal disease core indicators project.
Bailie GR; Frankenfield DL; Prowant BF; McClellan W; Rocco MV
Am J Kidney Dis; 1999 Jun; 33(6):1187-9. PubMed ID: 10352214
[TBL] [Abstract][Full Text] [Related]
9. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
10. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
Ahsan N
Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
[TBL] [Abstract][Full Text] [Related]
11. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
Fishbane S
Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
[TBL] [Abstract][Full Text] [Related]
12. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
Ahsan N
Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
[TBL] [Abstract][Full Text] [Related]
13. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
14. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive vision for intravenous iron therapy.
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
[TBL] [Abstract][Full Text] [Related]
16. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
[TBL] [Abstract][Full Text] [Related]
17. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
Kessler M; Landais P; Canivet E; Yver L; Bataille P; Brillet G; Commenges B; Koné S
Nephrol Ther; 2009 Apr; 5(2):114-21. PubMed ID: 19042175
[TBL] [Abstract][Full Text] [Related]
18. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
Kotaki M; Uday K; Henriquez M; Blum S; Dave M
Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
[No Abstract] [Full Text] [Related]
19. Does early anemia correction prevent complications of chronic renal failure?
Drüeke TB; Eckardt KU; Frei U; Jacobs C; Kokot F; McMahon LP; Schaefer RM
Clin Nephrol; 1999 Jan; 51(1):1-11. PubMed ID: 9988140
[TBL] [Abstract][Full Text] [Related]
20. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
McMahon LP
Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
